3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing.

Although it is expected that hepatocyte-like cells differentiated from human embryonic stem (ES) cells or induced pluripotent stem (iPS) cells will be utilized in drug toxicity testing, the actual applicability of hepatocyte-like cells in this context has not been well examined so far. To generate mature hepatocyte-like cells that would be applicable for drug toxicity testing, we established a hepatocyte differentiation method that employs not only stage-specific transient overexpression of hepatocyte-related transcription factors but also a three-dimensional spheroid culture system using a Nanopillar Plate. We succeeded in establishing protocol that could generate more matured hepatocyte-like cells than our previous protocol. In addition, our hepatocyte-like cells could sensitively predict drug-induced hepatotoxicity, including reactive metabolite-mediated toxicity. In conclusion, our hepatocyte-like cells differentiated from human ES cells or iPS cells have potential to be applied in drug toxicity testing.

[1]  K. Chayama,et al.  Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats. , 2001, The Biochemical journal.

[2]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[3]  Yasuhiko Tabata,et al.  Formation of hepatocyte spheroids with structural polarity and functional bile canaliculi using nanopillar sheets. , 2010, Tissue engineering. Part A.

[4]  K. Kume,et al.  Efficient Differentiation of Embryonic Stem Cells into Hepatic Cells In Vitro Using a Feeder-Free Basement Membrane Substratum , 2011, PloS one.

[5]  E. Gallagher,et al.  The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. , 1996, Toxicology and applied pharmacology.

[6]  H. Mizuguchi,et al.  Efficient and Directive Generation of Two Distinct Endoderm Lineages from Human ESCs and iPSCs by Differentiation Stage-Specific SOX17 Transduction , 2011, PloS one.

[7]  H. Hosomi,et al.  Development of a Highly Sensitive Cytotoxicity Assay System for CYP3A4-Mediated Metabolic Activation , 2011, Drug Metabolism and Disposition.

[8]  H. Mizuguchi,et al.  Efficient adenovirus vector‐mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation , 2008, The journal of gene medicine.

[9]  W. Cui,et al.  Application of three-dimensional culture conditions to human embryonic stem cell-derived definitive endoderm cells enhances hepatocyte differentiation and functionality. , 2013, Tissue engineering. Part A.

[10]  D. Cassio,et al.  Application of spheroid culture to human hepatocytes and maintenance of their differentiation , 1994, Biology of the cell.

[11]  R. Day,et al.  A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout its Withdrawal from the Market in the Best Interest , 2008 .

[12]  Hidenori Akutsu,et al.  Efficient Generation of Hepatoblasts From Human ES Cells and iPS Cells by Transient Overexpression of Homeobox Gene HEX , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  J. Maizel,et al.  The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. , 1974, Virology.

[14]  I. D. Román,et al.  Cyclosporin A induced internalization of the bile salt export pump in isolated rat hepatocyte couplets. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[15]  H. Mizuguchi,et al.  Efficient hepatic differentiation from human iPS cells by gene transfer. , 2012, Methods in molecular biology.

[16]  M. Kay,et al.  A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. , 1999, Human gene therapy.

[17]  Teruo Okano,et al.  Preserved liver-specific functions of hepatocytes in 3D co-culture with endothelial cell sheets. , 2012, Biomaterials.

[18]  Takao Hayakawa,et al.  The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets. , 2012, Biomaterials.

[19]  H. Mizuguchi,et al.  Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1α transduction. , 2012, Journal of hepatology.

[20]  T. Akaike,et al.  The differentiation and isolation of mouse embryonic stem cells toward hepatocytes using galactose-carrying substrata. , 2012, Biomaterials.

[21]  F Peter Guengerich,et al.  Applying mechanisms of chemical toxicity to predict drug safety. , 2007, Chemical research in toxicology.

[22]  R. Edwards,et al.  Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  Diana Kazolias,et al.  Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport , 2006, Drug Metabolism and Disposition.

[24]  N. J. Hewitt,et al.  Phase I and II enzyme characterization of two sources of HepG2 cell lines , 2004, Xenobiotica; the fate of foreign compounds in biological systems.

[25]  M. Kay,et al.  Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. , 1998, Human gene therapy.

[26]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .

[27]  P. Andrews,et al.  Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium , 2008, Proceedings of the National Academy of Sciences.

[28]  S. Yamanaka,et al.  Efficient reprogramming of human and mouse primary extra‐embryonic cells to pluripotent stem cells , 2009, Genes to cells : devoted to molecular & cellular mechanisms.

[29]  H. Hosomi,et al.  CYP2C9-Mediated Metabolic Activation of Losartan Detected by a Highly Sensitive Cell-Based Screening Assay , 2011, Drug Metabolism and Disposition.

[30]  Kei-ichi Minami,et al.  An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cells. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[31]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[32]  Hidenori Akutsu,et al.  Mesenchymal to embryonic incomplete transition of human cells by chimeric OCT4/3 (POU5F1) with physiological co-activator EWS. , 2009, Experimental cell research.

[33]  Smadar Cohen,et al.  Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions , 2004, Biotechnology and bioengineering.

[34]  Takao Hayakawa,et al.  Efficient Generation of Functional Hepatocytes From Human Embryonic Stem Cells and Induced Pluripotent Stem Cells by HNF4α Transduction. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.